Clinical Trials in Hanzhou, China
9 recruiting
Showing 1–20 of 44 trials
Recruiting
Phase 3
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
Leukemia Acute Myeloid - AML
Sunshine Lake Pharma Co., Ltd.324 enrolled1 locationNCT05586074
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled253 locationsNCT05899608
Recruiting
Phase 2
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc.75 enrolled11 locationsNCT05147467
Recruiting
Not Applicable
KD Treatment for Super-refractory Status Epilepticus
Super-refractory Status Epilepticus
Xuanwu Hospital, Beijing84 enrolled15 locationsNCT07496749
Recruiting
Phase 1
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.130 enrolled11 locationsNCT06375044
Recruiting
Not Applicable
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Schizophrenia
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT06470516
Recruiting
Micro-movements in Patients With Prolonged Disorders of Consciousness
Consciousness Disorders
First Affiliated Hospital of Zhejiang University179 enrolled1 locationNCT06406413
Recruiting
Phase 1Phase 2
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.121 enrolled2 locationsNCT06590246
Recruiting
Not Applicable
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease
Coronary artery stenosis
Duk-Woo Park, MD1,500 enrolled27 locationsNCT05831085
Recruiting
Phase 3
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd400 enrolled87 locationsNCT06079983
Recruiting
Phase 1
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University98 enrolled1 locationNCT04778839
Recruiting
Phase 1Phase 2
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled1 locationNCT06556199
Recruiting
Not Applicable
Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
Aortic Arch AneurysmPenetrating Aortic Ulcer
Lifetech Scientific (Shenzhen) Co., Ltd.103 enrolled17 locationsNCT06520774
Recruiting
Phase 1
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd288 enrolled7 locationsNCT05217693
Recruiting
Phase 3
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
Rectal Cancer
Sir Run Run Shaw Hospital170 enrolled1 locationNCT06507371
Recruiting
Phase 1Phase 2
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.133 enrolled1 locationNCT05133882
Recruiting
Phase 1
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT05472558
Recruiting
Not Applicable
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
Gaucher Disease, Type I
He Huang3 enrolled1 locationNCT06162338
Recruiting
Phase 2
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital20 enrolled2 locationsNCT05557578
Recruiting
Phase 2
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
Low rectal cancer
Sir Run Run Shaw Hospital32 enrolled1 locationNCT05972655